Literature DB >> 25059474

Organ procurement from executed prisoners in China.

A Sharif1, M Fiatarone Singh, T Trey, J Lavee.   

Abstract

Organ procurement from executed prisoners in China is internationally condemned, yet this practice continues unabated in 2014. This is despite repeated announcements from Chinese authorities that constructive measures have been undertaken to conform to accepted ethical standards. While there is unanimous agreement on the unethical nature of using organs from executed prisoners, due to its limitations on voluntary and informed consent, there is insufficient coverage of forced organ procurement from prisoners of conscience without consent. Strategies to influence positive change in China over the last few decades have failed to bring this practice to an end. While organ donation and transplantation services in China have undergone considerable structural changes in the last few years, fundamental attempts to shift practice to ethically sourced organs have floundered. In this article, we discuss the organ trade in China, reflect upon organ procurement from executed prisoners (including both capital prisoners and prisoners of conscience) and provide an overview of contradictory Chinese efforts to halt forced organ procurement from executed prisoners. Finally, we highlight current actions being taken to address this issue and offer comprehensive recommendations to bring this ethically indefensible practice to an immediate end. © Copyright 2014 The American Society of Transplantation and the American Society of Transplant Surgeons.

Keywords:  Ethics and public policy; editorial/personal viewpoint; ethics; law/legislation; organ procurement; organ procurement and allocation; organ sale/trade; organ transplantation in general

Mesh:

Year:  2014        PMID: 25059474     DOI: 10.1111/ajt.12871

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  10 in total

1.  China on the brink: there is hope for the end of their use of executed prisoner organs.

Authors:  Gabriel M Danovitch; Francis L Delmonico
Journal:  Hepatobiliary Surg Nutr       Date:  2015-04       Impact factor: 7.293

2.  Organ procurement from executed prisoners in China.

Authors:  Rudolf García-Gallont
Journal:  Hepatobiliary Surg Nutr       Date:  2015-04       Impact factor: 7.293

3.  Reforms in organ donation in China: still to be executed?

Authors:  Vivekanand Jha
Journal:  Hepatobiliary Surg Nutr       Date:  2015-04       Impact factor: 7.293

4.  Implementation of China's new policies on organ procurement: an important but challenging step forward.

Authors:  Dominique E Martin; Annika Tibell
Journal:  Hepatobiliary Surg Nutr       Date:  2015-04       Impact factor: 7.293

Review 5.  The need for xenotransplantation as a source of organs and cells for clinical transplantation.

Authors:  Burcin Ekser; David K C Cooper; A Joseph Tector
Journal:  Int J Surg       Date:  2015-07-16       Impact factor: 6.071

6.  Transplant Medicine in China: Need for Transparency and International Scrutiny Remains.

Authors:  T Trey; A Sharif; A Schwarz; M Fiatarone Singh; J Lavee
Journal:  Am J Transplant       Date:  2016-09-19       Impact factor: 8.086

7.  Human rights violations in organ procurement practice in China.

Authors:  Norbert W Paul; Arthur Caplan; Michael E Shapiro; Charl Els; Kirk C Allison; Huige Li
Journal:  BMC Med Ethics       Date:  2017-02-08       Impact factor: 2.652

8.  Historical development and current status of organ procurement from death-row prisoners in China.

Authors:  Kirk C Allison; Arthur Caplan; Michael E Shapiro; Charl Els; Norbert W Paul; Huige Li
Journal:  BMC Med Ethics       Date:  2015-12-03       Impact factor: 2.652

9.  Nobel Peace Prize nomination for Doctors Against Forced Organ Harvesting (DAFOH) - a recognition of upholding ethical practices in medicine.

Authors:  Alan Šućur; Srećko Gajović
Journal:  Croat Med J       Date:  2016-06-30       Impact factor: 1.351

10.  The outcomes and controversies of transplant tourism-Lessons of an 11-year retrospective cohort study from Taiwan.

Authors:  Daniel Fu-Chang Tsai; Shi-Wei Huang; Soren Holm; Yi-Ping Lin; Yu-Kang Chang; Chih-Cheng Hsu
Journal:  PLoS One       Date:  2017-06-02       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.